DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on February 27 for the period ending December 31 2024
The New York City-based company is expected to report a 35.0% decrease in revenue to $129.424 million from $199.25 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for DocGo Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DocGo Inc is $6.50, above its last closing price of $4.44.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.04 | 0.05 | 0.05 | Met | 2.9 |
Jun. 30 2024 | 0.06 | 0.08 | 0.07 | Missed | -6.7 |
Mar. 31 2024 | 0.07 | 0.08 | 0.10 | Beat | 22.8 |
Dec. 31 2023 | 0.09 | 0.10 | 0.07 | Missed | -30 |
Sep. 30 2023 | 0.05 | 0.06 | 0.05 | Missed | -18.9 |
Jun. 30 2023 | 0.03 | 0.03 | -0.02 | Missed | -166.7 |
Mar. 31 2023 | 0.02 | 0.02 | -0.03 | Missed | -238.4 |
Dec. 31 2022 | 0.05 | 0.08 | Beat | 60 |
This summary was machine generated February 25 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。